CME Group Inc. CME
264.48
(4.43)
(1.65%)
as of 25 Sep
- Market cap
- $96.5B
- P/E
- 22.3×
Follow CME
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
CME Group Inc. (CME) P/B ratio
As of 25 September 2026, CME Group Inc. (CME) trades at a P/B ratio of 3.6×. Over the past ten years it has ranged from 1.3× (January 2016) to 4.2× (April 2026); the current reading is higher than 94% of that period. That is below the Financial Data & Stock Exchanges industry median of 3.8× and above the Financial sector median of 1.3×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 3.4× | 8.50% |
| FY2024 | 3.2× | 12.16% |
| FY2023 | 2.8× | 24.60% |
| FY2022 | 2.3× | (24.54%) |
| FY2021 | 3.0× | 20.89% |
| FY2020 | 2.5× | (9.81%) |
| FY2019 | 2.7× | 10.49% |
| FY2018 | 2.5× | 13.35% |
| FY2017 | 2.2× | 15.28% |
| FY2016 | 1.9× | 28.06% |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 3.0× | (24.67%) |
| Mar 2026 | 4.0× | 16.62% |
| Dec 2025 | 3.4× | (0.83%) |
| Sep 2025 | 3.4× | (3.53%) |
| 42 more quarters | Free account |
Against its own ten years
Low 1.3×
High 4.2×
Ten-year median
2.5×
Current reading's percentile
94
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| MSCI MSCI Inc compare | n/m |
| TRU TransUnion compare | 2.7× |
| ICE Intercontinental Exchange Inc. compare | 2.9× |
| CME CME Group Inc. | 3.6× |
| SPGI S&P Global Inc. compare | 3.8× |
| COIN Coinbase Global, Inc. compare | 3.9× |
| NDAQ Nasdaq, Inc. compare | 4.4× |
| CBOE Cboe Global Markets, Inc. compare | 4.8× |
| MCO Moody's Corporation compare | 25.8× |
| Financial Data & Stock Exchanges industry median | 3.8× |
| Financial sector median | 1.3× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on CME
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement